Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Dec 25;18(24):7243-50.
doi: 10.1093/nar/18.24.7243.

Mutations that alter the ability of the Escherichia coli cyclic AMP receptor protein to activate transcription

A Bell  1 , K Gaston, R Williams, K Chapman, A Kolb, H Buc, S Minchin, J Williams, S Busby
Affiliations
Free PMC article

Mutations that alter the ability of the Escherichia coli cyclic AMP receptor protein to activate transcription

A Bell et al. Nucleic Acids Res. .
Free PMC article

Abstract

The effects of a number of mutations in the E. coli cyclic AMP receptor protein (CRP) have been determined by monitoring the in vivo expression and in vitro open complex formation at two semi-synthetic promoters that are totally CRP-dependent. At one promoter the CRP-binding site is centered around 41.5 base pairs upstream from the transcription start whilst at the other promoter it is 61.5 base pairs upstream. The CRP mutation E171K reduces expression from both promoters whilst H159L renders CRP totally inactive: neither mutation stops CRP binding at either promoter. The mutations K52N and K52Q reverse the effect of H159L and 'reeducate' CRP to activate transcription. CRP carrying both H159L and K52N activates transcription from the promoter with the CRP site at -41.5 better than wild type CRP. In sharp contrast, this doubly changed CRP is totally inactive with respect to the activation of transcription from the promoter carrying the CRP site at -61.5. Our results suggest that CRP can use different contacts and/or conformations during transcription activation at promoters with different architectures.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. EMBO J. 1985 Dec 1;4(12):3329-32 - PubMed
    1. Proc Natl Acad Sci U S A. 1984 Jul;81(13):3973-7 - PubMed
    1. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8315-9 - PubMed
    1. J Mol Biol. 1987 Nov 20;198(2):311-26 - PubMed
    1. Nucleic Acids Res. 1988 Aug 11;16(15):7315-32 - PubMed

Publication types

Substances